Fisher K - Search Results

1

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.

Kuhn I, Harden P, Bauzon M, Chartier C, Nye J, Thorne S, Reid T, Ni S, Lieber A, Fisher K, Seymour L, Rubanyi GM, Harkins RN, Hermiston TW. Kuhn I, et al. Among authors: fisher k. PLoS One. 2008 Jun 18;3(6):e2409. doi: 10.1371/journal.pone.0002409. PLoS One. 2008. PMID: 18560559 Free PMC article.

2

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus.

Green NK, Herbert CW, Hale SJ, Hale AB, Mautner V, Harkins R, Hermiston T, Ulbrich K, Fisher KD, Seymour LW. Green NK, et al. Among authors: fisher kd. Gene Ther. 2004 Aug;11(16):1256-63. doi: 10.1038/sj.gt.3302295. Gene Ther. 2004. PMID: 15215884

3

Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins.

Stevenson M, Hale AB, Hale SJ, Green NK, Black G, Fisher KD, Ulbrich K, Fabra A, Seymour LW. Stevenson M, et al. Among authors: fisher kd. Cancer Gene Ther. 2007 Apr;14(4):335-45. doi: 10.1038/sj.cgt.7701022. Epub 2007 Jan 19. Cancer Gene Ther. 2007. PMID: 17235355

4

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.

Bazan-Peregrino M, Carlisle RC, Hernandez-Alcoceba R, Iggo R, Homicsko K, Fisher KD, Halldén G, Mautner V, Shen Y, Seymour LW. Bazan-Peregrino M, et al. Among authors: fisher kd. Hum Gene Ther. 2008 Sep;19(9):873-86. doi: 10.1089/hum.2008.047. Hum Gene Ther. 2008. PMID: 18710328

5

Adenovirus: teaching an old dog new tricks.

Seymour LW, Fisher KD. Seymour LW, et al. Hum Gene Ther. 2011 Sep;22(9):1041-2. doi: 10.1089/hum.2011.2517. Hum Gene Ther. 2011. PMID: 21932993 No abstract available.

6

Virotherapy--cancer targeted pharmacology.

Tedcastle A, Cawood R, Di Y, Fisher KD, Seymour LW. Tedcastle A, et al. Drug Discov Today. 2012 Mar;17(5-6):215-20. doi: 10.1016/j.drudis.2011.12.011. Epub 2011 Dec 16. Drug Discov Today. 2012. PMID: 22198165 Review.

7

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.

Green NK, Hale A, Cawood R, Illingworth S, Herbert C, Hermiston T, Subr V, Ulbrich K, van Rooijen N, Seymour LW, Fisher KD. Green NK, et al. Among authors: fisher kd. Nanomedicine (Lond). 2012 Nov;7(11):1683-95. doi: 10.2217/nnm.12.50. Epub 2012 Jun 18. Nanomedicine (Lond). 2012. PMID: 22709345

8

Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood.

Di Y, Seymour L, Fisher K. Di Y, et al. Among authors: fisher k. Gene Ther. 2014 Apr;21(4):440-3. doi: 10.1038/gt.2014.2. Epub 2014 Feb 20. Gene Ther. 2014. PMID: 24553347

9

A PTENtial cause for the selectivity of oncolytic viruses?

Champion BR, Fisher K, Seymour L. Champion BR, et al. Among authors: fisher k. Nat Immunol. 2016 Mar;17(3):225-6. doi: 10.1038/ni.3394. Nat Immunol. 2016. PMID: 26882253 No abstract available.

10

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.

Dyer A, Di Y, Calderon H, Illingworth S, Kueberuwa G, Tedcastle A, Jakeman P, Chia SL, Brown A, Silva MA, Barlow D, Beadle J, Hermiston T, Ferguson DJ, Champion B, Fisher KD, Seymour LW. Dyer A, et al. Mol Ther Oncolytics. 2016 Dec 10;4:18-30. doi: 10.1016/j.omto.2016.11.003. eCollection 2017 Mar 17. Mol Ther Oncolytics. 2016. PMID: 28345021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,650 results

Search Page